sharetrader
Page 2132 of 2135 FirstFirst ... 1132163220322082212221282129213021312132213321342135 LastLast
Results 21,311 to 21,320 of 21342
  1. #21311
    Senior Member
    Join Date
    Mar 2010
    Posts
    974

    Default

    Quote Originally Posted by snigmac View Post
    It's on the PEB website. Some of it is here
    https://www.pacificedgedx.com/news-a...-medicare-lcd/ ,but the information will be scattered across a few pages.
    Been around too long to accept what Pacific Edge say..
    Have you seen any evidence to support claim that these groups support Detects inclusion?

  2. #21312
    Member
    Join Date
    Aug 2021
    Location
    Christchurch
    Posts
    248

    Default

    Quote Originally Posted by carrom74 View Post
    A query- what if there is no decision made in the times mentioned. BAU??
    Quote Originally Posted by psychic View Post
    Been around too long to accept what Pacific Edge say..
    Have you seen any evidence to support claim that these groups support Detects inclusion?
    Nothing specific about Detect but Cxbladder is mentioned expressly in their letter and the groups advocate for Medicare coveragw for Cxbladder to be kept. There letter can e donnloaded here: https://www.pacificedgedx.com/assets...CD-DL39365.pdf

  3. #21313
    Senior Member
    Join Date
    Mar 2010
    Posts
    974

    Default

    Quote Originally Posted by snigmac View Post
    Nothing specific about Detect but Cxbladder is mentioned expressly in their letter and the groups advocate for Medicare coveragw for Cxbladder to be kept. There letter can e donnloaded here: https://www.pacificedgedx.com/assets...CD-DL39365.pdf
    Thank you. Note as a group they argue for the continued inclusion of approved Biomarkers generally and agree, they speak positively of the results of the unpublished Kaiser findings. But note that AUA does not include the use of Cxbladder in its own Clinical Guidelines....
    Wouldn't you think the AUA would first change their guidelines if Cxbladder had their support?

  4. #21314
    Senior Member
    Join Date
    Jun 2016
    Posts
    501

    Default

    Quote Originally Posted by psychic View Post
    Thank you. Note as a group they argue for the continued inclusion of approved Biomarkers generally and agree, they speak positively of the results of the unpublished Kaiser findings. But note that AUA does not include the use of Cxbladder in its own Clinical Guidelines....
    Wouldn't you think the AUA would first change their guidelines if Cxbladder had their support?
    A podium presentation of the clinical utility was part of the just concluded AUA conference.Not sure what weight this would carry but worth to note that this conference was attended by a lot of urologists across the world.

    https://api.nzx.com/public/announcem...284-417563.pdf

  5. #21315
    Member
    Join Date
    Aug 2021
    Location
    Christchurch
    Posts
    248

    Default

    Quote Originally Posted by carrom74 View Post
    A query- what if there is no decision made in the times mentioned. BAU??
    I'm not an expert on AUA and guidelines. Reading between the lines, I think it takes time and research for inclusion. I think PEB is gunning for inclusion in guidelines, it's just not there yet. AUA is expressly supportive of the PEB tests and they have noted this in their letter. I think the safest thing for Novitas to do is to trigger another modified LCD and give PEB another year of coverage.
    Last edited by snigmac; 23-06-2024 at 09:46 PM.

  6. #21316
    Senior Member
    Join Date
    Mar 2010
    Posts
    974

    Default

    Quote Originally Posted by carrom74 View Post
    A podium presentation of the clinical utility was part of the just concluded AUA conference.Not sure what weight this would carry but worth to note that this conference was attended by a lot of urologists across the world.

    https://api.nzx.com/public/announcem...284-417563.pdf
    Yeah, been multiple CxBladder podium presentations over the years at AUA Conferences

  7. #21317
    Senior Member
    Join Date
    Jun 2016
    Posts
    501

    Default

    Quote Originally Posted by psychic View Post
    Yeah, been multiple CxBladder podium presentations over the years at AUA Conferences
    This time though on a randomised STRATA study… randomised but funded by PEB.

  8. #21318
    Senior Member
    Join Date
    Mar 2010
    Posts
    974

    Default

    Quote Originally Posted by snigmac View Post
    I'm not an expert on AUA and guidelines. Reading between the lines, I think it takes time and research for inclusion. I think PEB is gunning for inclusion in guidelines, it's just not there yet. AUA is expressly supportive of the PEB tests and they have noted this in their letter. I think the safest thing for Novitas to do is to trigger another modified LCD and give PEB another year of coverage.
    From the 2024 AUA guidelines
    In surveillance of NMIBC, a clinician should not use urinary biomarkers in place of cystoscopic evaluation. (Strong Recommendation; Evidence Strength: Grade B)

  9. #21319
    Member
    Join Date
    Aug 2021
    Location
    Christchurch
    Posts
    248

    Default

    Quote Originally Posted by psychic View Post
    From the 2024 AUA guidelines
    In surveillance of NMIBC, a clinician should not use urinary biomarkers in place of cystoscopic evaluation. (Strong Recommendation; Evidence Strength: Grade B)
    This is a article pushed out a few days ago: https://auanews.net/issues/articles/...cer-management .Cxbladder is mentioned and biomarkers are talked about favorably. The science is getting there... just not sure how far or close it is for inclusion...

    There is also a part that comments on guidelines:

    AUA guidelines do not currently recommend the use of urinary biomarkers to replace cystoscopy, but they do provide two clinical scenarios where biomarkers may be useful: (1) to adjudicate equivocal cytology or indeterminate cystoscopic findings and (2) to assess response to bacillus Calmette-Guérin (BCG).
    Last edited by snigmac; 23-06-2024 at 10:30 PM.

  10. #21320
    Senior Member
    Join Date
    Mar 2010
    Posts
    974

    Default

    Yes, article talks generally about biomarkers, not written by AUA as such. Big mention re opposition too.

    In the two clinical scenarios you refer to the biomarkers approved are UroVysion Fish and Immunocyt, not CxBladder.

    Totally agree, getting there. But still seems some way off.
    Last edited by psychic; 23-06-2024 at 10:57 PM.

Tags for this Thread

Bookmarks

Posting Permissions

  • You may not post new threads
  • You may not post replies
  • You may not post attachments
  • You may not edit your posts
  •